Does Lyrica Reduce Fibromyalgia Pain?
Lyrica (pregabalin) is FDA-approved for fibromyalgia pain management in adults. Clinical trials showed it reduces pain scores by 30-50% in about 30-40% of patients, compared to 20-25% on placebo. A key phase 3 trial (n=529) reported average pain reduction of 2.1 points on an 11-point scale versus 1.3 for placebo after 3 months.[1][2]
How Does Lyrica Work for Fibromyalgia?
It binds to calcium channels in the central nervous system, reducing neurotransmitter release that amplifies pain signals. This targets fibromyalgia's widespread pain and tenderness, distinct from its use in neuropathic pain from nerve damage.[1]
What Do Clinical Studies Show?
FDA approval stemmed from four double-blind trials (2,446 patients total). Doses of 300-450 mg/day yielded statistically significant pain relief (p<0.01), plus improvements in sleep, fatigue, and function. Response rates: 38% for 450 mg vs. 19% placebo. Long-term data (up to 6 months) confirmed sustained effects, though 20-30% discontinued due to side effects.[2][3]
Common Side Effects and Risks
Dizziness (30-45%), somnolence (20-30%), dry mouth, and weight gain (7-10%) occur most often. Serious risks include blurred vision, edema, and dependency potential; abrupt stop can cause withdrawal. Not recommended for those with heart failure or creatinine clearance under 60 mL/min.[1][4]
How Does It Compare to Alternatives?
Lyrica outperforms placebo more than duloxetine (Cymbalta) or milnacipran (Savella) in head-to-head meta-analyses for pain reduction, but duloxetine edges out on mood symptoms. Amitriptyline is cheaper but sedating; gabapentin is similar but off-label and less potent at equivalent doses. No head-to-head fibromyalgia trial directly pits Lyrica against opioids, which carry higher addiction risk.[3][5]
Who Responds Best and When to Expect Relief?
Patients with moderate-to-severe pain (score >4/10) and poor sleep see fastest benefits, often within 1-2 weeks at 150-300 mg/day (titrated up). Non-responders after 4-6 weeks rarely improve. Women (80% of fibromyalgia cases) show similar efficacy to men.[2]
Cost and Availability Details
Generic pregabalin costs $20-50/month (30-day supply) versus $400+ for brand Lyrica. Patents expired in 2018-2019; multiple generics available.[6]
[1]: FDA Label - Lyrica (Pregabalin), https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021446s035,022488s013lbl.pdf
[2]: Crofford LJ et al. NEJM 2005;352:1326-1335, https://www.nejm.org/doi/full/10.1056/NEJMoa050730
[3]: Häuser W et al. Pain 2017;158:60-68, https://pubmed.ncbi.nlm.nih.gov/27750069/
[4]: Pfizer Safety Data, https://www.lyrica.com/
[5]: Cooper TE et al. Cochrane Database Syst Rev 2017, https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012708.pub2/full
[6]: DrugPatentWatch.com - Pregabalin Patents, https://www.drugpatentwatch.com/p/tradename/LYRICA